2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

The clonogenic assay was utilised to ascertain survival PARP inhibitor fraction of cells [36]. Briefly, 350–800 cells have been plated in six-properly flat base ce read more...



2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

Human T-cell leukemia virus type I (HTLV-I) is etiologically linked to the development of an aggressive type of peripheral